Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.

LEADER 00000cam  2200601Ii 4500 
001    1081038408 
003    OCoLC 
005    20190808062250.3 
006    m     o  d         
007    cr cnu---unuuu 
008    190107s2019    sz a    ob    001 0 eng d 
015    GBB918425|2bnb 
020    9783319969299|q(electronic bk.) 
020    3319969293|q(electronic bk.) 
020    |z3319969285 
020    |z9783319969282 
035    (OCoLC)1081038408 
037    com.springer.onix.9783319969299|bSpringer Nature 
040    N$T|beng|erda|epn|cN$T|dN$T|dEBLCP|dGW5XE|dUKMGB|dOCLCF
       |dUAB|dCOO|dOCLCQ 
049    MAIN 
050  4 RB131 
072  7 MED|x014000|2bisacsh 
072  7 MED|x022000|2bisacsh 
072  7 MED|x112000|2bisacsh 
072  7 HEA|x039000|2bisacsh 
072  7 MED|x045000|2bisacsh 
082 04 616/.0473|223 
245 00 Auto-inflammatory syndromes :|bpathophysiology, diagnosis,
       and management /|ceditor, Petros Efthimiou. 
264  1 Cham :|bSpringer,|c[2019] 
264  4 |c2019. 
300    1 online resource :|billustrations (some color) 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
340    |gpolychrome|2rdacc|0http://rdaregistry.info/termList/
       RDAColourContent/1003 
347    text file|2rdaft|0http://rdaregistry.info/termList/
       fileType/1002 
504    Includes bibliographical references and index. 
505 0  Intro; Foreword; Preface; Contents; Contributors; Author 
       Biography; Chapter 1: Immunology of Auto-inflammatory 
       Syndromes; Introduction to Innate Immunity and 
       Autoinflammation; Microbial Sensors: NODs, NOD-Like 
       Receptors, and the Inflammasomopathies; Pyrin Inflammasome
       Dysfunction as a Common Feature of Autoinflammation; 
       Cytokines as Key Mediators of Innate Immunity and 
       Autoinflammation; Type I Interferon Response and 
       Interferonopathies; Conclusions and the Road Ahead; 
       References; Part I: Monogenic Autoinflammatory Diseases 
505 8  Chapter 2: Mevalonate Kinase Deficiency (MKD)/
       Hyperimmunoglobulin D Syndrome (HIDS)Introduction; 
       Pathophysiology and Genetics; Organ Manifestations; Rare 
       Manifestations; Pregnancy; Treatment; Conclusion; 
       References; Chapter 3: The TNF Receptor-Associated 
       Autoinflammatory Syndrome (TRAPS); Introduction; 
       Pathogenesis; Clinical Presentation; Treatment; 
       References; Chapter 4: PAPA Syndrome and the Spectrum of 
       PSTPIP1-Associated Inflammatory Diseases; Introduction; 
       Spectrum of PSTPIP1-Associated Inflammatory Diseases; 
       Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) 
       Syndrome 
505 8  PSTPIP1-Associated Myeloid-Related Proteinemia 
       Inflammatory (PAMI) SyndromePyoderma Gangrenosum, Acne, 
       and Ulcerative Colitis (PAC); Pyogenic Arthritis, Pyoderma
       Gangrenosum, Acne, and Hidradenitis Suppurativa (PAPASH); 
       and PAPA-Like Syndrome; Pathogenetic Mechanisms; Structure
       and Functions of PSTPIP1; Interaction with Pyrin and the 
       Inflammasome; Increased Interleukin (IL)-1 Secretion; Role
       of Myeloid-Related Proteins (MRP) 8 and 14; Organization 
       of Cytoskeletal Structures and Cellular Dynamics; 
       Regulation of Osteoclast Activity; Interactions with the 
       Adaptive Immune System; Treatment 
505 8  Mucocutaneous ManifestationsExtracutaneous Manifestations;
       Laboratory; Pathology; Genetics; Functional Studies; 
       Diagnosis; Prognosis; Treatment; References; Chapter 8: 
       Cryopyrin-Associated Periodic Syndromes (CAPS); 
       Introduction; Epidemiology; Genetics and Pathophysiology; 
       Clinical Phenotypes; Diagnosis and Classification; 
       Inflammatory Markers; Additional Testing; Monitoring of 
       Children and Adults with CAPS; Treatment; Outcome; 
       References; Chapter 9: Familial Mediterranean Fever; 
       Genetics; Pathogenesis; Clinical Manifestations; 
       Laboratory Investigations; Diagnosis; Treatment; 
       References 
520    References; Chapter 5: Blau Syndrome; Introduction; 
       Clinical Features; Dermatitis; Arthritis; Uveitis; Other 
       Manifestations; Pathophysiology; Genetic Mutations; 
       Histology and Morphology; Diagnosis; Management; 
       Prognosis; Summary; References; Chapter 6: Deficiency of 
       the Interleukin-1 Receptor Antagonist (DIRA); Clinical 
       Manifestations; Laboratory; Genetics; Functional 
       Implications; Animal Models; Diagnosis and Differential 
       Diagnosis; Prognosis; Treatment; References; Chapter 7: 
       Deficiency of the Interleukin-36 Receptor Antagonist 
       (DITRA) and Generalized Pustular Psoriasis; Epidemiology 
588 0  Print version record. 
650  0 Inflammation.|0http://id.loc.gov/authorities/subjects/
       sh85066108 
650  0 Immunologic diseases.|0http://id.loc.gov/authorities/
       subjects/sh85064571 
655  4 Electronic books. 
700 1  Efthimiou, Petros,|0http://id.loc.gov/authorities/names/
       n2019188821|eeditor. 
776 08 |iPrint version:|tAUTO-INFLAMMATORY SYNDROMES.|d[Place of 
       publication not identified], SPRINGER INTERNATIONAL PU, 
       2018|z3319969285|w(OCoLC)1042079846. 
990    SpringerLink|bSpringer English/International eBooks 2019 -
       Full Set|c2019-08-07|yNew collection 
       springerlink.ebooks2019|5OH1 
LOCATION CALL # STATUS MESSAGE
 OHIOLINK SPRINGER EBOOKS    ONLINE  
View online

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team